Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 61
Filter
1.
Diabetes Metab Syndr ; 15(5): 102208, 2021.
Article in English | MEDLINE | ID: mdl-34298274

ABSTRACT

BACKGROUND: Diabetes mellitus, a metabolic disorder characterized by hyperglycaemia is due to impaired insulin secretion and deficiency. Though effective current drug therapies are available for diabetes, yet glycaemic maintenance remains a challenge without medication adherence. This necessitates a holistic approach to improve clinical outcomes for a better patient health care. METHODS: A prospective, interventional, randomized controlled study was conducted among 97 type 2 diabetic patients for 6 months. The primary outcome measures included patient satisfaction of care assessment by diabetes treatment satisfaction questionnaire (DTSQ) and medication adherence by medication adherence rating scale (MARS). Secondary outcomes included assessment of knowledge, attitude, and perception and laboratory parameters. The collected data was analyzed using paired and unpaired T-test. RESULTS: Of 97 patients randomized to group A (n = 49) and group B (n = 48), there were 3 and 1 drop-out in group A and B, respectively. The mean age of patients was found to be 56.82 ± 4.06 years. At the 6thmonth follow up, significant improvement of glycaemic parameters was observed in group A vs B. Mean MARS and DTSQ scores also improved in group A vs. B (P-value <0.05). CONCLUSION: Pharmacist-provided counselling improves patient compliance, quality of life and satisfaction of care in diabetic patients.


Subject(s)
Biomarkers/blood , Diabetes Mellitus, Type 2/drug therapy , Hypoglycemic Agents/therapeutic use , Medication Adherence/statistics & numerical data , Patient Satisfaction , Pharmacists/statistics & numerical data , Quality of Life , Adult , Aged , Aged, 80 and over , Blood Glucose/analysis , Female , Follow-Up Studies , Glycated Hemoglobin/analysis , Humans , Male , Middle Aged , Prognosis , Prospective Studies
2.
Mol Ecol ; 21(20): 5027-41, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22998157

ABSTRACT

Arylalkylamine N-acetyltransferase-2 (AANAT2) is the enzyme responsible for the rhythmic production of the time-keeping hormone melatonin. It plays a crucial role in the synchronization of biological functions with changes in the environment. Annual and daily fluctuations in light are known to be key environmental factors involved in such synchronization. Previous studies have demonstrated that AANAT2 activity is also markedly influenced by temperature but the mechanisms through which it impacts the enzyme activity need to be further deciphered. We investigated AANAT2 primary to tertiary structures (3D models) and kinetics in relation to temperature for a variety of Teleost species from tropical to Arctic environments. The results extend our knowledge on the catalytic mechanisms of AANAT enzymes and bring strong support to the idea that AANAT2 diversification was limited by stabilizing selection conferring to the enzyme well conserved secondary and tertiary structures. Only a few changes in amino acids appeared sufficient to induce different enzyme activity patterns. It is concluded that AANAT2 evolution is mainly driven by phylogenetic relationships although catalytic properties (enzyme turnover and substrate affinity) are also under the influence of the respective species normal habitat temperature.


Subject(s)
Arylalkylamine N-Acetyltransferase/genetics , Ecosystem , Evolution, Molecular , Fishes/genetics , Temperature , Amino Acid Sequence , Animals , Circadian Rhythm , Cloning, Molecular , Enzyme Stability , Gene Expression Regulation, Enzymologic , Melatonin/biosynthesis , Models, Molecular , Molecular Sequence Data , Phylogeny , Protein Structure, Secondary , Protein Structure, Tertiary , Recombinant Proteins/genetics , Substrate Specificity
3.
Cytopathology ; 23(4): 242-9, 2012 Aug.
Article in English | MEDLINE | ID: mdl-21736645

ABSTRACT

OBJECTIVE: In recent years, therapeutic approaches including cytoreductive surgery followed by intraperitoneal chemotherapy have proven effective in peritoneal carcinomatosis of colorectal origin. If cytology is to be used to include patients in aggressive treatment regimens, it is necessary to evaluate its performance, particularly in terms of specificity. The aim of this study was to assess interobserver agreement for the detection of intraperitoneal free cancer cells (IFCCs) in patients with non-gynaecological adenocarcinomas. METHODS: Over a 5-year period, 1223 patients were recruited in 19 French surgery departments. Peritoneal samples were examined in 14 dispersed pathology laboratories. Giemsa-stained slides were sent to a control reader blind to the previous diagnosis. Discordant cases, concordant positive results and a random selection of negative concordant cases were reviewed by a panel of seven cytopathologists. The 'final diagnosis' was that of the consensus meetings but took into account locally-processed slides. RESULTS: Gathering dubious cases with negative results, a 95.6% concordance was achieved between local readers and the control reader. IFCCs were ascertained by the panel in 85 cases (7.0%). Eight of 873 colorectal cancers cases viewed locally were falsely positive (0.9%). Radiotherapy and neoadjuvant therapy had no impact on the false-positive rate as assessed by final validation by the panel (P > 0.05). Samples initially considered as dubious were reclassified as negative by the panel in 24 of 25 cases (96.0%). CONCLUSIONS: The panel consensus allowed reclassification of most dubious/equivocal peritoneal cytology cases, whereas clearcut distinction between benign and malignant cases was correctly achieved in almost all cases.


Subject(s)
Adenocarcinoma/diagnosis , Colorectal Neoplasms/diagnosis , Cytodiagnosis , Peritoneum/pathology , Adenocarcinoma/pathology , Adolescent , Adult , Aged , Aged, 80 and over , Carcinoma/diagnosis , Colorectal Neoplasms/pathology , Humans , Middle Aged , Prognosis , Reproducibility of Results , Retrospective Studies
4.
J Fish Biol ; 74(5): 1104-28, 2009 Apr.
Article in English | MEDLINE | ID: mdl-20735622

ABSTRACT

The phylogenetic relationships among populations of seaperch, Helicolenus spp., in the south-west Pacific were examined with mtDNA markers. Parts of the cytochrome b gene [459 base pair (bp)] and the control region (448 bp) were sequenced in 58 specimens from the south-west Pacific and four specimens of Helicolenus lengerichi from Chile. Only one clade was recognized in New Zealand coastal waters, despite a wide range of colour morphs. This clade also occurred in the mid Tasman Sea on the Norfolk Ridge and around Tasmania and Victoria. A second sympatric clade was identified around Tasmania and Victoria and to the west of New Zealand. A third allopatric clade was identified to the north of New Zealand and in deep water on the Chatham Rise and a fourth clade on the Foundation Seamounts and the Louisville Ridge. Helicolenus lengerichi from Chile formed a fifth clade. Assuming a molecular clock, the clades were estimated to have diverged c. 0.7-2.6 million years ago. Only two clades, around Tasmania and Victoria, were separated using morphology, colour (in live) and dorsal-fin soft ray counts and were confirmed as Helicolenus percoides and Helicolenus barathri. Two characters, orbit diameter and colour variation, previously used to identify two species in New Zealand waters were unreliable characters for species discrimination. Principle component analyses of 11 morphological measures from 67 individuals did not delineate the clades. A canonical discriminant analysis was able to separate four of the five clades, but mean discriminate probabilities were low (77.6%), except for the five Chilean specimens of H. lengerichi (100%).


Subject(s)
Evolution, Molecular , Perches/genetics , Phylogeny , Animals , Chile , DNA, Mitochondrial/genetics , New Zealand , Pacific Ocean , Perches/anatomy & histology , Perches/classification , Principal Component Analysis , Sequence Alignment , Sequence Analysis, DNA
5.
Spectrochim Acta A Mol Biomol Spectrosc ; 69(5): 1294-300, 2008 May.
Article in English | MEDLINE | ID: mdl-18006375

ABSTRACT

Two types of automatic fitting procedures for EPR spectra of disordered systems have been developed, one based on matrix diagonalization of a general spin Hamiltonian, the other on 2nd order perturbation theory. The first program is based on a previous Fortran code complemented with a newly written interface in Java to provide user-friendly in and output. The second is intended for the special case of free radicals with several relatively weakly interacting nuclei, in which case the general method becomes slow. A least squares' fitting procedure utilizing analytical or numerical derivatives of the theoretically calculated spectrum with respect to the g- and hyperfine structure (hfs) tensors was used to refine those parameters in both cases. 'Rigid limit' ESR spectra from radicals in organic matrices and in polymers, previously studied experimentally at low temperature, were analyzed by both methods. Fluorocarbon anion radicals could be simulated, quite accurately with the exact method, whereas automatic fitting on, e.g. the c-C(4)F(8)(-) anion radical is only feasible with the 2nd order approximative treatment. Initial values for the (19)F hfs tensors estimated by DFT calculations were quite close to the final. For neutral radicals of the type XCF(2)CF(2)* the refinement of the hfs tensors by the exact method worked better than the approximate. The reasons are discussed. The ability of the fitting procedures to recover the correct magnetic parameters of disordered systems was investigated by fittings to synthetic spectra with known hfs tensors. The exact and the approximate methods are concluded to be complementary, one being general, but limited to relatively small systems, the other being a special treatment, suited for S=1/2 systems with several moderately large hfs.


Subject(s)
Electron Spin Resonance Spectroscopy/methods , Fluorocarbons/chemistry , Inorganic Chemicals/chemistry , Computer Simulation
6.
Br J Dermatol ; 155(3): 552-6, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16911280

ABSTRACT

BACKGROUND: Recurrence after treatment of stage I-II melanoma involves regional lymph nodes in about 50% of patients. A reliable method is needed to evaluate lymph node status (metastatic or not) in the case of palpable lymph nodes. OBJECTIVES: To evaluate the efficiency of fine-needle aspiration biopsy (FNAB) in examining clinically detected suspicious lymph node in patients followed up after surgical removal of stage I-II melanoma. PATIENTS AND METHODS: One hundred and twenty FNABs were performed in 67 patients with a suspicious node in an open study conducted in a French melanoma regional referral centre, Hôpital de l'Hôtel-Dieu. Cytodiagnosis was classified as positive, negative, inadequate or inconclusive. Sensitivity, specificity, positive and negative predictive values and positive and negative likelihood ratios were calculated after final histopathological evaluation. RESULTS: Fifty-eight of 120 FNABs were positive (48%), 50 of 120 (42%) were negative, four of 120 (3%) were inconclusive and eight of 120 (7%) were inadequate. Among the 108 FNABs in which a definitive diagnosis could be given, sensitivity was 98.2% [95% confidence interval (CI) 90.7-99.9] and specificity was 96.1% (95% CI 86.8-98.9). CONCLUSIONS: FNAB under ultrasound guidance is an efficient tool to discriminate better between cases in which surgical treatment of the lymph node basin should be performed and patients who should return for follow-up. Surgical treatment appears to be required in cases of positive FNAB or in inconclusive cases.


Subject(s)
Melanoma/secondary , Skin Neoplasms , Ultrasonography, Interventional , Adult , Aged , Aged, 80 and over , Biopsy, Fine-Needle/methods , Epidemiologic Methods , Female , Humans , Lymphatic Metastasis , Male , Melanoma/diagnostic imaging , Melanoma/pathology , Middle Aged , Palpation
7.
Morphologie ; 90(288): 21-5, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16929817

ABSTRACT

PURPOSE: Glass slides and standard microscopes associated to a brief review of the lectures with projection slides were used during practical training in histology and histopathology for many years. Today it is necessary to develop new tools to improve teaching, and to face a lower number of teachers, as well the increase of the microscope maintenance costs. The goal of this study was to evaluate the feasibility of virtual slide implantation in several medical schools, the feedback from students, and to develop the interest in microscopic histology. METHODS: We used virtual slides generated by the Samba 2050 system produced by Samba technologies. A collection of all organs for histology training was realized and overviewed by three MD, PhD. A questionnaire was distributed in middle of the year to evaluate the feedback. RESULTS: The feedback of the students is highly positive. Students works faster, on better resources, interactivity between students is increased, and the fact that this is a new modality of teaching raises the students' interest. CONCLUSION: Today the teaching program in two French medical schools (Lyon and Grenoble) include virtual slides alone or in addition to microscopic glass slide examination to teach histology or pathology.


Subject(s)
Histology/education , Schools, Medical , France , Image Processing, Computer-Assisted/standards , Microscopy/methods , Pathology/education , Pilot Projects , Teaching , User-Computer Interface
8.
J Phys Chem B ; 109(27): 13312-21, 2005 Jul 14.
Article in English | MEDLINE | ID: mdl-16852661

ABSTRACT

This paper presents an experimental infrared spectroscopic study of the physisorption of trichloroethylene (TCE) and tetrachloroethylene (PCE) on a self-supported high silica ZSM5 zeolite. The evolution of the shape, area, and location of vibration bands of both the adsorbent and the adsorbate is analyzed with respect to the number of sorbed molecules. The state of the adsorbed phase is characterized upon adsorption by comparing the location of the investigated vibration bands with the location of the corresponding vibration bands of the chloroalkenes in gaseous, liquid, and solid phases. The singular behavior of PCE with respect to TCE is seen from the modification of vibration bands of both the adsorbed phase and the adsorbent upon loading. The adsorption process proceeds by stages for PCE, whereas it appears continuous for TCE. Particular micropore loadings are evidenced at 4 and 6.5 molec.uc(-1) for PCE and at 6 molec.uc(-1) for TCE, in agreement with previous macroscopic and microscopic data. In addition, the presence of admolecules induces at least one emerging vibration band located at around 1715 cm(-1), mainly due to a contribution of the microporous surface of the adsorbent.

9.
J Endocrinol ; 183(1): 79-90, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15525576

ABSTRACT

In utero exposure to exogenous anti-androgenic compounds induces a wide range of abnormalities of the reproductive system, including hypospermatogenesis, cryptorchidism and hypospadias. By using rats exposed in utero to the anti-androgenic compound flutamide (0.4, 2 or 10 mg/kg per day), it has been shown that hypospermatogenesis in adult testes could be related to (i) a long-term apoptosis in germ cells but not in somatic Leydig and Sertoli cells as evidenced by the TUNEL approach and (ii) alterations in the mRNA and protein expression of pro- (Bax, Bak, Bid) and anti-apoptotic (Bcl-2, Bcl-w) members of the Bcl-2 family. Indeed, the number of apoptotic germ cells increased with the dose of flutamide administered and the apoptotic germ cells were mainly detected at androgen-dependent stages VII-VIII. Moreover, for the Bcl-2-related proteins that were expressed mainly in the germ cells, a decrease in the levels of anti-apoptotic peptides Bcl-w (60%, P=0.003) and Bcl-2 (90%, P=0.0001) was observed at 2 mg/kg per day flutamide and an increase in levels of the pro-apoptotic Bax (2.3-fold, P=0.0004) was detected at 10 mg/kg per day. In contrast, the levels of pro-apoptotic peptide Bak that was mainly expressed in somatic cells decreased (70%, P=0.0008) at 10 mg/kg per day. Such alterations in Bcl-2-related peptides occurred mainly at the protein level except for Bcl-2 (72%, P=0.0001) and Bak (43%, P=00002) transcripts. Together, these results showed that the apoptosis observed in adult germ cells from rats exposed in utero to flutamide may result from a long-term alteration in the balance between pro- and anti-apoptotic Bcl-2-related molecules in favour of pro-apoptotic proteins. These data further supported the concept of an androgen-dependent fetal programming that is in relation with an alteration of the expression of Bcl-2-related genes/proteins promoting apoptosis in testicular germ cells of adult rats with fetal androgen disruption.


Subject(s)
Androgen Antagonists/toxicity , Embryonic Development/drug effects , Flutamide/toxicity , Prenatal Exposure Delayed Effects , Spermatozoa/drug effects , Androgen Antagonists/metabolism , Animals , Apoptosis/genetics , Dose-Response Relationship, Drug , Female , Flutamide/metabolism , Gene Expression/drug effects , Genes, bcl-2 , Immunohistochemistry/methods , In Situ Nick-End Labeling , Male , Mitochondria/drug effects , Mitochondria/metabolism , Pregnancy , Rats , Rats, Sprague-Dawley , Spermatogenesis/drug effects , Spermatozoa/cytology
10.
Ann Biol Clin (Paris) ; 62(4): 446-50, 2004.
Article in French | MEDLINE | ID: mdl-15297240

ABSTRACT

Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most frequent enzyme deficiency. It is a sex-linked genetic disease concerning mostly african, mediterranean and far-eastern populations. The main clinical expression is a hemolytic anemia which can be acute or chronic. During the neonatal period the disease may manifest as neonatal jaundice. We have been asked by the neonate department to set up a blood screening test for this deficiency. We have therefore developed a test using umbilical cord blood. The assay of G6PD has been automatised and red blood cell aspartate-amino-transferase (ASAT) chosen as a reference enzyme to evaluate the age of red blood cells. Normal values of G6PD, ASAT and G6PD/ASAT ratio have been calculated from 235 cord samples. Genetic frequency of this deficiency in 2002 was 6% in male and 1% in female newborns.


Subject(s)
Erythrocytes , Fetal Blood , Glucosephosphate Dehydrogenase Deficiency/diagnosis , Glucosephosphate Dehydrogenase/analysis , Neonatal Screening/methods , Acute Disease , Anemia, Hemolytic/genetics , Aspartate Aminotransferases/analysis , Chronic Disease , Erythrocyte Aging , Erythrocytes/chemistry , Erythrocytes/enzymology , Female , Fetal Blood/chemistry , Fetal Blood/enzymology , France/epidemiology , Gene Frequency , Genetic Variation/genetics , Glucosephosphate Dehydrogenase Deficiency/epidemiology , Glucosephosphate Dehydrogenase Deficiency/genetics , Glucosephosphate Dehydrogenase Deficiency/metabolism , Humans , Incidence , Infant, Newborn , Jaundice, Neonatal/genetics , Male , Neonatal Screening/standards , Prevalence , Reference Values , Sensitivity and Specificity , Sex Distribution
11.
Cancer ; 92(1): 77-84, 2001 Jul 01.
Article in English | MEDLINE | ID: mdl-11443612

ABSTRACT

BACKGROUND: The authors performed a specific analysis of the clinical significance of inguinal lymph nodes metastases in patients with anal canal carcinoma (ACC). METHODS: A retrospective analysis was conducted of 270 patients who were treated in Lyon between 1980 and 1996 with radiotherapy with curative intent for ACC: No elective irradiation of clinically normal inguinal areas was performed. Patients with metastatic inguinal lymph nodes were treated with inguinal dissection and postoperative irradiation with a dose of 50 grays over 5 weeks. Concomitant chemoradiation, usually with a regimen of fluorouracil and cisplatinum, was given to 159 patients. RESULTS: The median follow-up for the whole series was 72 months. Synchronous inguinal metastases were observed in 10% of patients (n = 27; the rate was 16% for patients with T3--T4 lesions), and the 5-year overall survival rate was 54.4%. Metachronous inguinal metastases were seen in 19 patients (7.8%), and the 5-year overall survival rate of these patients was 41.4%. An original finding was that, when the primary tumor clearly was located on a single lateral side of the anal canal, the inguinal lymphatic metastases was always homolateral to it (36 of 36 synchronous plus metachronous tumors). CONCLUSIONS: The data from this series of patients and a review of the literature are in favor of a selective approach in the management of inguinal lymph node involvement for patients with ACC, depending on the disease stage and the location of the primary tumors.


Subject(s)
Anus Neoplasms/therapy , Adult , Aged , Aged, 80 and over , Anus Neoplasms/pathology , Female , Follow-Up Studies , Humans , Inguinal Canal , Lymphatic Metastasis , Male , Middle Aged , Neoplasms, Second Primary/therapy , Retrospective Studies
12.
Thorax ; 54(12): 1093-8, 1999 Dec.
Article in English | MEDLINE | ID: mdl-10567629

ABSTRACT

BACKGROUND: Cystic fibrosis (CF) is a genetic disease caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene and defective expression of CFTR protein in epithelial cells. The main cause of mortality in CF is linked to chronic inflammatory and infectious airway processes. Recent studies have suggested perturbations in the apoptotic process in CF cell lines and enterocytes. A study was undertaken to investigate the expression of Fas and Fas ligand (FasL) in CF bronchial epithelium and CF tracheal cell lines. METHODS: Immunohistochemical staining for Fas (alkaline phosphatase anti-alkaline phosphatase) and FasL (immunoperoxidase) was performed in eight CF bronchial epithelial samples and four controls and immunohistochemical DNA fragmentation (TUNEL) was carried out in four CF patients and four controls. Immunofluorescence staining and flow cytometric analysis of Fas and FasL expression was performed in two human tracheal epithelial cell lines (HTEC) with normal and CF genotype. The dosage of serum soluble FasL was examined in 21 patients with CF and 14 healthy volunteers. RESULTS: FasL expression was markedly increased in patients with CF in both the ciliated and submucosal glandular bronchial epithelium compared with controls; Fas was similarly expressed in bronchial samples from controls and CF patients in both the ciliated epithelium and submucosal glands. High levels of DNA fragmentation were observed in CF but with some epithelial cell alterations. Serum concentrations of soluble FasL were frequently undetectable in patients with CF. In vitro, HTEC expressed Fas and FasL in both genotypes. A higher mean fluorescence intensity for FasL expression was noted in CF genotype HTEC with median (range) for six experiments of 74 (25-101) for CF cells and 42 (21-70) for non-CF cells. CONCLUSION: Fas/FasL interaction is probably implicated in the human CF airway apoptotic pathway. The mechanisms of induction of FasL expression and its role in inducing tissue damage or remodelling or in controlling local inflammatory cell apoptosis remain to be determined.


Subject(s)
Cystic Fibrosis/metabolism , Membrane Glycoproteins/metabolism , fas Receptor/metabolism , Adolescent , Adult , Apoptosis , Child , Cystic Fibrosis/genetics , Epithelial Cells/metabolism , Fas Ligand Protein , Female , Flow Cytometry , Humans , Immunohistochemistry , Male , Membrane Glycoproteins/genetics , Trachea/metabolism , fas Receptor/genetics
13.
Eur J Endocrinol ; 139(2): 209-16, 1998 Aug.
Article in English | MEDLINE | ID: mdl-9724079

ABSTRACT

Structural alterations to proto-oncogene sequences may be involved in the pathogenesis of human thyroid neoplasms. We studied 128 thyroid tumours (35 benign and 93 malignant) for ras gene point mutations in three different codons (12, 13 and 61) using a restriction fragment length polymorphism technique and direct sequencing of double-stranded DNA on polymerase chain-reaction-amplified tumour DNA. We found a high frequency of ras mutation for the Ha-ras codon 12 in follicular adenomas (7 of 35), particularly in atypical adenomas (5 of 17), in follicular carcinomas (6 of 19), with a high percentage for Hurthle cell carcinomas (6 of 11), and in papillary carcinomas (4 of 66). Point mutations for other ras genes in different codons studied were weak to absent. No mutation was found in undifferentiated carcinomas (n = 8). The predominant amino acid substitution both in the adenomas and in the differentiated tumours was glycine to valine (GGC to GTC) at position 12 of the Ha-ras gene. Our results obtained on a large series confirm the frequent occurrence of Ha-ras codon 12 gene mutations both in adenomas and in carcinomas. The frequency of ras mutations is linked to the geographical origin of the population studied and varies (0-85%) from one cancer type to another according to published data. Therefore, these mutations are merely an expression of cellular transformation.


Subject(s)
Genes, ras/genetics , Point Mutation , Thyroid Neoplasms/genetics , Adenocarcinoma, Follicular/genetics , Adenocarcinoma, Papillary/genetics , Adenoma/genetics , Carcinoma/genetics , DNA Mutational Analysis , DNA, Neoplasm/analysis , Humans , Proto-Oncogene Mas , Sequence Analysis, DNA
14.
Presse Med ; 26(16): 752-5, 1997 May 17.
Article in French | MEDLINE | ID: mdl-9205469

ABSTRACT

OBJECTIVE: Fine-needle aspiration (FNA) is now considered as the first-line investigation for the diagnosis of thyroid nodules. We searched for a more accurate and cost-effective methodology as this technique fails to recognized hot nodules, frequent in certain countries. PATIENTS AND METHODS: A prospective study was conducted in 150 patients to compare two diagnostic procedures: scintigraphy first combined with FNA in case of cold nodules versus TSH measurement plus FNA when TSH measurement plus FNA when TSH was not depressed. The results were subjected to cost/benefit analysis. RESULTS: Cystic nodules were found in 28 cases (including 3 hyperfunctionning nodules, with 5 suspicious smears (1 carcinoma). FNA was non-diagnostic in 26 patients; 12 were operated on (1 carcinoma), 14 had further FNA (5 suspicious, 9 benign). Altogether 56 nodules were removed, for toxic adenoma (n = 5), for suspicious (n = 21) or malignant (n = 12) smear, or on personal (n = 18) demand; 16 carcinomas were found (2 medullary, 13 capillary, 1 follicular carcinomas). With scintigraphy first, the cost was 787 French francs (FF) per patient. With TSH measurement and FNA, the cost was 554 FF per patient. In both cases, the same number of carcinomas were removed, and all the hot nodules (11 including 5 toxic adenomas) were detected. CONCLUSION: Serum TSH measurement, with scintigraphy if TSH is low, and FNA in all the other cases, is accurate and more cost-effective than scintigraphy as a first-line investigation for the diagnosis of thyroid nodule.


Subject(s)
Thyroid Nodule/diagnosis , Thyrotropin/blood , Biopsy, Needle , Cost-Benefit Analysis , Diagnosis, Differential , Female , Humans , Male , Prospective Studies , Radionuclide Imaging , Thyroid Neoplasms/blood , Thyroid Neoplasms/diagnosis , Thyroid Neoplasms/diagnostic imaging , Thyroid Nodule/blood , Thyroid Nodule/diagnostic imaging
15.
Hum Gene Ther ; 8(1): 15-25, 1997 Jan 01.
Article in English | MEDLINE | ID: mdl-8989991

ABSTRACT

Ad CFTR, a replication-deficient adenovirus expressing the human cystic fibrosis transmembrane conductance regulator (CFTR), was administered by aerosolization in a single escalating dose to three pairs (cohorts) of cystic fibrosis (CF) patients. Buffer only was administered to the nose and lungs 9-14 days before nasal instillation of virus followed the day after by aerosolization of Ad CFTR to the lung. Nasal doses (defined in terms of viral plaque forming units, pfu) were 10(5), 10(7), and 4 x 10(8), whereas aerosolized doses were 10(7), 10(8), 5.4 x 10(8) for each cohort, respectively. No acute toxic effects were observed in the first 4 weeks after virus treatment. Shedding of infectious Ad CFTR was never detected, whereas detection of vector DNA sequences and CFTR expression demonstrated DNA transfer to the nose and airways of patients. No significant deviations in immunological and inflammatory parameters were observed in serum and in bronchoalveolar lavage (BAL). Importantly, for all patients, the serum anti-adenovirus antibody levels did not change significantly from baseline and no antibodies against adenovirus were found in BAL.


Subject(s)
Adenoviridae/metabolism , Aerosols/therapeutic use , Cystic Fibrosis Transmembrane Conductance Regulator/metabolism , Genetic Therapy , Adolescent , Adult , Blotting, Southern , Bronchoalveolar Lavage , Cystic Fibrosis Transmembrane Conductance Regulator/analysis , Cystic Fibrosis Transmembrane Conductance Regulator/genetics , DNA/analysis , Female , Gene Expression/genetics , Genetic Vectors/genetics , Humans , Immunohistochemistry , Male , Nasal Mucosa/cytology , Nasal Mucosa/metabolism , Polymerase Chain Reaction , RNA, Messenger/analysis
16.
Rev Mal Respir ; 13(3): 295-9, 1996 Jul.
Article in French | MEDLINE | ID: mdl-8765923

ABSTRACT

This retrospective study was performed to evaluate the interest of cytology in the diagnosis of pulmonary carcinomas. Bronchial samples were collected from 330 patients known to display a macroscopic lesion which was detected by bronchoscopy. Cytological analysis of the bronchial brushings and washings, removed at the first fibroscopy, allowed the diagnosis of malignancy in 92% of the cases analyzed whereas the biopsy confirmed the malignancy in 77% of the cases. In conclusion cytological studies gave information on malignity and classification in 90% of the cases. However histological classification only could guarantee the choice of the best treatment regimen.


Subject(s)
Biopsy , Carcinoma/pathology , Cytodiagnosis , Lung Neoplasms/pathology , Adenocarcinoma/pathology , Biopsy/methods , Bronchoscopy , Carcinoma/classification , Carcinoma, Large Cell/pathology , Carcinoma, Small Cell/pathology , Carcinoma, Squamous Cell/pathology , Clinical Protocols , Cytodiagnosis/instrumentation , Cytodiagnosis/methods , Evaluation Studies as Topic , Fiber Optic Technology , Humans , Lung Neoplasms/classification , Lymphoma/pathology , Patient Care Planning , Retrospective Studies , Sensitivity and Specificity
17.
Int J Cancer ; 67(1): 29-34, 1996 Jul 03.
Article in English | MEDLINE | ID: mdl-8690521

ABSTRACT

The p16INK4 tumor-suppressor gene (also known as CDKN2, CDK41 and MTS1) encodes a negative regulator of the cell cycle. This gene, located in 9p21, is mutated or homozygously deleted in a high percentage of tumor cell lines and specific types of primary tumors. We have examined the status of the p16INK4 gene in 31 thyroid tumors and 7 thyroid cell lines. No DNA abnormalities were found in primary tumors. Conversely, p16INK4 gene structural alterations, deletions and point mutations were found in 4 thyroid cell lines. The expression of the 2 different p16INK4 mRNAs, the p16alpha and p16beta transcripts, was determined by RNA-PCR experiments. All the primary thyroid tumors expressed the beta transcript, while the p16alpha was barely detectable. The thyroid cell lines always expressed the p16beta transcript, while the alpha transcript was absent or, whenever present, coded for a mutated form of the p16INK4 gene product. Taken together, our results suggest that loss of p16INK4 function is not directly involved in the process of thyroid-tumor development, but it probably gives cells in tissue culture a selective growth advantage.


Subject(s)
Carrier Proteins/genetics , Cell Cycle Proteins , Genes, Tumor Suppressor , Thyroid Neoplasms/genetics , Tumor Suppressor Proteins , Amino Acid Sequence , Base Sequence , Carrier Proteins/analysis , Cyclin-Dependent Kinase Inhibitor p15 , Cyclin-Dependent Kinase Inhibitor p16 , Humans , Molecular Sequence Data , Mutation , Polymerase Chain Reaction , RNA, Messenger/analysis , Tumor Cells, Cultured
18.
Eur J Endocrinol ; 134(2): 177-83, 1996 Feb.
Article in English | MEDLINE | ID: mdl-8630516

ABSTRACT

OBJECTIVE: p53 is a well-known nuclear phosphoprotein encoded by a suppressor gene know to be mutated in various kinds of human tumours. A relationship between p53 gene mutation and tumour progression seems to be a common feature of several neoplasias. DESIGN: In order to investigate the role of p53 mutations in human thyroid tumours, DNA samples derived from fifty-six neoplastic tissues, ranging from benign adenomas to undifferentiated carcinomas, were examined for the presence of p53 gene mutations. METHODS: The analysis has been conducted using polymerase chain reaction (PCR) amplification of the exons 5-9 of the p53 gene followed by single strand conformation polymorphism (SSCP) and sequence analyses. RESULTS: One anaplastic carcinoma and one papillary carcinoma showed p53 gene mutations in exons 5 and 8, respectively. A cell line established from the papillary carcinoma showed the same mutation present in the original tumour. Both p53 mutations were heterozygous. The p53 positive samples were analysed for other genetic alterations frequently detected in human thyroid carcinomas (mutations of the RET, TRK, and ras oncogenes): both p53-mutated samples proved to be mutated at level of codon 13 of the c-Ki-ras gene. CONCLUSIONS: Our data confirm that p53 gene alterations are rare in well-differentiated thyroid tumours, that they are an important requirement for the establishment in culture of human thyroid carcinoma cell lines, and that they can be associated with other genetic alterations, namely ras mutations, in the malignant progression of thyroid tumours.


Subject(s)
Genes, p53 , Genes, ras , Mutation , Thyroid Neoplasms/genetics , Base Sequence , DNA, Neoplasm/analysis , Exons , Humans , Immunohistochemistry , Molecular Sequence Data , Polymerase Chain Reaction , Polymorphism, Single-Stranded Conformational
19.
C R Seances Soc Biol Fil ; 190(1): 109-42, 1996.
Article in French | MEDLINE | ID: mdl-8881273

ABSTRACT

At present it is conceivable to think that gene therapy represents a way to treat or even prevent the respiratory manifestations of cystic fibrosis. Consistent to such a concept, there is sufficient evidence that Ad-CFTR, a recombinant replication-deficient adenovirus expressing the human cystic fibrosis transmembrane conductance regulator cDNA, can vectorize the expression of a functional CFTR (cystic fibrosis transmembrane conductance regulator) to the nasal and airway epithelia. The clinical protocol was designed to assess the safety of single escalating doses of a replication defective adenovirus expressing the cystic fibrosis transmembrane conductance regulator gene (Ad-CFTR) when administered to the tracheobronchial portion of the airways and whether biological efficacy of CFTR delivery could be demonstrated. Six cystic fibrosis patients received nasal instillation and subsequent aerosol (Optineb, Air Liquide, Paris, France) administration of Ad-CFTR the following day. Doses (pfu) applied to the nose were 10(5) (patients SG and PB), 10(7) (patients FP and EP) and 4 x 10(8) (patients DS and FG), while aerosolised doses were 10(7) (patients SG and PB), 10(8) (patients FP and EP) and 5.4 x 10(8) (patients DS and FG), respectively. No acute toxic effects, no increase in the titer of anti-adenovirus antibodies and no spreading or shedding of Ad-CFTR were detected. In one patient Ad-CFTR DNA was found in the urine and blood two days after aerosolisation. Ad-CFTR DNA was detected in nasal and bronchial brush samples, in BAL, in saliva and tonsils 21, 8, 14 and 4 days post virus administration, respectively. Ad-CFTR mRNA (RT-PCR on bronchial cells) and CFTR protein (immunochemistry on nasal and bronchial cells) were detected up to 14 days following Ad-CFTR administration. These results show that the nebulisation of Ad-CFTR is a possible approach for treating the respiratory manifestation of cystic fibrosis.


Subject(s)
Adenoviridae/genetics , Cystic Fibrosis Transmembrane Conductance Regulator/administration & dosage , Cystic Fibrosis Transmembrane Conductance Regulator/genetics , Cystic Fibrosis/therapy , DNA, Recombinant/administration & dosage , Gene Transfer Techniques , Genetic Vectors/genetics , Adolescent , Adult , Aerosols , Animals , Defective Viruses/genetics , Drug Tolerance , Genetic Therapy/methods , Humans , Recombination, Genetic , Relative Biological Effectiveness , Respiratory System/virology
20.
Clin Chim Acta ; 235(2): 197-206, 1995 Mar 31.
Article in English | MEDLINE | ID: mdl-7554274

ABSTRACT

An immunoradiometric assay using two monoclonal antibodies directed to human trypsin 1 was developed for measuring trypsin(ogen) in biological fluids. The assay is different from other assays in that it is specific for cationic trypsinogen and does not recognize the alpha-1-proteinase inhibitor-trypsin complex. It can be used as a complement to classical immunoassays to characterize trypsinogen activation in pathological cases. The evaluation and the specificity of the assay are presented.


Subject(s)
Alpha-Globulins/analysis , Immunoradiometric Assay/methods , Trypsin Inhibitors/analysis , Trypsin/analysis , Trypsinogen/analysis , Amniotic Fluid/enzymology , Animals , Humans , Pancreatic Juice/enzymology , Radioimmunoassay , Rats , Swine , Trypsin/blood , Trypsin Inhibitors/blood , Trypsinogen/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...